Status:

WITHDRAWN

A Phase 2 Study With CC-220 in Skin Sarcoidosis

Lead Sponsor:

Celgene

Conditions:

Sarcoidosis

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

This study will evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of oral CC-220 in adult subjects with chronic cutaneous sarcoidosis.

Detailed Description

This is a Phase 2a, multicenter, randomized, double-blind, placebo-controlled, sequential, dose-ascending, safety and tolerability study in subjects with chronic cutaneous sarcoidosis. Two dose cohor...

Eligibility Criteria

Inclusion

  • Males or females aged ≥ 18 years at the time of consent.
  • Have chronic cutaneous sacrcoidosis (CCS) prior to consent
  • Have active cutaneous sarcoidosis lesion(s) at screening
  • Forced vital capacity of ≥ 45% of predicted normal value at screening.
  • Estimated Glomerular Filtration Rate (eGFR) ≥ 60 mL/min.
  • Females of childbearing potential must have negative pregnancy tests prior to starting study therapy and agree to either commit to true abstinence or use effective contraception.
  • Male subjects must practice true abstinence or agree to use a condom even if he has undergone a successful vasectomy

Exclusion

  • Positive tuberculosis test at screening.
  • History of inadequately treated tuberculosis
  • History of Human Immunodeficiency Virus (HIV) and/or Common Variable Immunodeficiency Disease.
  • History of alcohol or drug abuse
  • History or current peripheral neuropathy
  • Current uveitis or any other clinically significant ophthalmological finding
  • Currently require therapy for precapillary pulmonary hypertension.

Key Trial Info

Start Date :

November 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2017

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT02192489

Start Date

November 1 2014

End Date

June 30 2017

Last Update

November 12 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

A Phase 2 Study With CC-220 in Skin Sarcoidosis | DecenTrialz